Literature DB >> 8201704

Diabetes mellitus and experimental vein graft structure and function.

M G Davies1, J H Kim, M L Klyachkin, L Barber, H Dalen, E Svendsen, C C Carson, P O Hagen.   

Abstract

PURPOSE: Diabetes mellitus is a known risk factor for accelerated atherosclerosis and for postangioplasty restenosis.
METHODS: This study examines the effect of chronic, uncontrolled, alloxan-induced diabetes on the structure and vasomotor function of vein bypass grafts in 20 male New Zealand white rabbits with diabetes and in 10 controls. After 8 weeks of diabetes, a common carotid vein bypass graft was performed. Four weeks after operation, vein grafts and contralateral jugular veins were harvested.
RESULTS: Diabetes induced a twofold increase in the vein graft intimal thickness compared with control. There was no change in medial thickness. Electron microscopy of the vein grafts in diabetes revealed intercellular gaps in the endothelium lining and abnormal endothelial cell junctions compared with controls. Diabetes significantly increased the maximal contractions generated in vein grafts to all contractile agonists tested without any change in sensitivity.
CONCLUSIONS: This study demonstrates that diabetes alters endothelial cell structure and increases the development of intimal hyperplasia with increased maximal contractility in vein grafts and therefore suggests that the vein grafts in diabetes are more susceptible to early stenosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201704     DOI: 10.1016/s0741-5214(94)70215-2

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

Review 1.  Nanozyme-based colorimetric biosensor with a systemic quantification algorithm for noninvasive glucose monitoring.

Authors:  Hee-Jae Jeon; Hyung Shik Kim; Euiheon Chung; Dong Yun Lee
Journal:  Theranostics       Date:  2022-09-07       Impact factor: 11.600

2.  Effect of metabolic syndrome on the response to arterial injury.

Authors:  Yuyang Fu; Enrico A Duru; Mark G Davies
Journal:  J Surg Res       Date:  2014-05-27       Impact factor: 2.192

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.